4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000005
CFO and Secretary sold 10,757 shares at an average $9.10 ($97,864)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2025-01-13 | Sale 10b5-1 | −10,657 | $9.09 | $96,901 | 226,197 | D |
| Levy Adam Scott CFO and Secretary | 2025-01-13 | Sale 10b5-1 | −100 | $9.63 | $963 | 226,097 | D |
| Open-market sales · 10,757 sh · avg $9.10 · $97,864 | |||||||
Loading xslF345X05/wk-form4_1736995563.xml…